Insight

Karen Knudsen: One of the greatest feelings as a scientist is watching your mentees support each other throughout their careers

Collage photo of Karen Knudsen and Saswati Chand

Nov 6, 2024, 17:26

Karen Knudsen: One of the greatest feelings as a scientist is watching your mentees support each other throughout their careers

“One of the greatest feelings as a scientist is watching your mentees both thrive and support each other throughout their careers.

I could not be more proud of the K2 lab trainee alums, who are now moving and shaking the oncology world, including Ayesha Shafi and Saswati Chand.”

Quoting

“Wrapping up this month by highlighting and congratulating Ayesha Shafi and her team at CPDR for bringing this manuscript to the finish line. Elated to see my post-doc neck-deep-in-COVID experiments finally see the light of the day.

Huge shout out to our mentor Karen Knudsen for helping foster career-long collaborations. CCS1477 is in clinical trials for advanced tumors and heme malignancies.”

“AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer”

Authors: Sumaira Sardar, Christopher McNair, Lakshmi Ravindranath, Saswati Chand, Karen Knudsen, Ayesha Shafi et al.

Karen Knudsen: One of the greatest feelings as a scientist is watching your mentees support each other throughout their careers

More posts featuring Karen Knudsen.

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.

She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers.

She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.